chr6-79489163-TG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001122769.3(LCA5):c.1151delC(p.Pro384fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,460,812 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
LCA5
NM_001122769.3 frameshift
NM_001122769.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.23
Genes affected
LCA5 (HGNC:31923): (lebercilin LCA5) This gene encodes a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Alternatively spliced transcript variants are described. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 15 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-79489163-TG-T is Pathogenic according to our data. Variant chr6-79489163-TG-T is described in ClinVar as [Pathogenic]. Clinvar id is 966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-79489163-TG-T is described in Lovd as [Pathogenic]. Variant chr6-79489163-TG-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCA5 | NM_001122769.3 | c.1151delC | p.Pro384fs | frameshift_variant | 7/8 | ENST00000369846.9 | NP_001116241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCA5 | ENST00000369846.9 | c.1151delC | p.Pro384fs | frameshift_variant | 7/8 | 1 | NM_001122769.3 | ENSP00000358861.4 | ||
LCA5 | ENST00000392959.5 | c.1151delC | p.Pro384fs | frameshift_variant | 8/9 | 1 | ENSP00000376686.1 | |||
LCA5 | ENST00000467898.3 | c.1151delC | p.Pro384fs | frameshift_variant | 7/7 | 5 | ENSP00000474463.1 | |||
ENSG00000231533 | ENST00000652956.1 | n.469+7726delG | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250504Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135434
GnomAD3 exomes
AF:
AC:
1
AN:
250504
Hom.:
AF XY:
AC XY:
1
AN XY:
135434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460812Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726748
GnomAD4 exome
AF:
AC:
11
AN:
1460812
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
726748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Leber congenital amaurosis 5 Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2007 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 03, 2023 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Leber congenital amaurosis Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 20, 2023 | Variant summary: LCA5 c.1151delC (p.Pro384GlnfsX18) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic in ClinVar and are associated with Leber Congenital Amaurosis in HGMD. The variant allele was found at a frequency of 4e-06 in 250504 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1151delC has been reported in the literature in multiple individuals affected with Leber Congenital Amaurosis/early-onset retinal degeneration and has been shown to segregate with disease (e.g., denHollander_2007, MacKay_2013, Li_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) have cited the variant, and both laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change creates a premature translational stop signal (p.Pro384Glnfs*18) in the LCA5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 314 amino acid(s) of the LCA5 protein. This variant is present in population databases (rs386834252, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with LCA5-related retinal dystrophy (PMID: 17546029, 26352687). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 966). This variant disrupts a region of the LCA5 protein in which other variant(s) (p.Lys586*) have been determined to be pathogenic (PMID: 23946133, 27624628). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at